national stem-cell therapy logo

2022 WMIF | The Cell Therapy Landscape | CAR-T to Stem Cells

Help Spread The Word, Share Post:

Cell therapies, ranging from CAR-T cells to stem-cell-based approaches, are emerging as a transformative therapeutic modality. Panelists will examine this emerging landscape and discuss a range of key topics. What drives differentiation in this space given the high number of competing technologies? How will the uptake of autologous cell therapies and allogeneic versions evolve? When will the regenerative medicine market mature?

Credit: World Medical Innovation Forum


Marcela Maus, MD, PhD, Director, Cellular Immunotherapy Program, Cancer Center, MGH; Associate Professor, Medicine, HMS

Christina Coughlin, MD, PhD, CEO, CytoImmune

Rachel Haurwitz, PhD, President & CEO, Caribou Biosciences

Nick Leschly, CEO, 2seventy bio

Dhvanit Shah, PhD, President & CEO, Garuda Therapeutics

Rusty Williams, MD, PhD, Chairman & CEO, Walking Fish Therapeutics

*** All content on is for informational purposes only. All medical questions and concerns should always be consulted with your licensed healthcare provider.

*** Our website contains affiliate advertisements. We may receive a commission for purchases made through these ads at no additional cost to you.

Stay Connected

More Updates